Snowed-Out Sarepta Panel Likely Delays FDA Verdict
This article was originally published in Scrip
Executive Summary
With a major winter snowstorm that's expected to slam the Washington area – snarling traffic, delaying airline flights and wreaking havoc in general – the FDA decided to postpone the highly anticipated Jan. 22 meeting of the agency's Peripheral and Central Nervous System (PCNS) Drugs Advisory Committee, although regulators gave panelists, patient advocates and others planning to attend the hearing little warning ahead of time.